Copyright
©The Author(s) 2023.
World J Stem Cells. Aug 26, 2023; 15(8): 787-806
Published online Aug 26, 2023. doi: 10.4252/wjsc.v15.i8.787
Published online Aug 26, 2023. doi: 10.4252/wjsc.v15.i8.787
Figure 1 Interferon-gamma induced the expression of programmed cell death protein 1 ligand 1 in human umbilical-cord-mesenchymal stem cells.
A-C: Programmed cell death protein 1 ligand 1 (PD-L1) expression was measured by quantitative real-time PCR (qRT-PCR), flow cytometry, and western blot in human umbilical-cord-mesenchymal stem cells (hUC-MSCs) treated with 0, 10, 20, 40, 60, 80 or 100 ng/mL interferon-gamma (IFN-γ) for 24 h; D-F: PD-L1 expression was measured by qRT-PCR, flow cytometry, and western blot in hUC-MSCs treated with 20 ng/mL IFN-γ for 0, 2, 4, 6, 8, 12, 24 or 48 h. Data were represented as mean ± SEM of n = 3. Iso: Isotype; C: Control; aP < 0.01; bP < 0.001. IFN-γ: Interferon-gamma; PD-L1: Programmed cell death protein 1 ligand 1.
- Citation: Chen Z, Yao MW, Shen ZL, Li SD, Xing W, Guo W, Li Z, Wu XF, Ao LQ, Lu WY, Lian QZ, Xu X, Ao X. Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression. World J Stem Cells 2023; 15(8): 787-806
- URL: https://www.wjgnet.com/1948-0210/full/v15/i8/787.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i8.787